Corrigendum: Effect of itraconazole on the safety and pharmacokinetics of antitumor SHR6390

In the published article, there was an error in the Author list, and author Xiaozhi Lv was erroneously listed as the third author, not the first. The corrected Author list appears below.

“Xiaozhi Lv, Junyan Wu*, Herui Yao*, Suiwen Ye, Nan Zhang”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

In the published article, there was an error in the Funding statement. It was erroneously left out. The correct Funding statement appears below.

Funding

The authors declare that financial support was received for the research, authorship, and/or publication of this article. Funding went to principal investigator JW for the name of the clinical trial sponsor—itraconazole against SHR6390 in healthy subjects trial. This study was funded by Jiangsu Hengrui Pharmaceutical Co., Ltd. The involvement of funder in the study is as follows: the funders only participated in the design of national clinical trials, and the subsequent data collection, analysis and interpretation were all completed by the researchers of our center. The funders did not participate in the writing of this paper or the decision of whether to publish it.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.